Safety of Key Inhaled and Intravenous Drugs in Pediatrics: (SAFEKIDS) Initiative
MedSun: Newsletter #56, January 2011

FDA Website

Recent non-clinical studies in juvenile animal models show that exposure to some anesthetics and sedatives is associated with memory and learning deficits. SAFEKIDS is a multi-year effort to address major gaps in scientific information concerning the safety of anesthetics and sedatives in pediatric age groups. FDA has also partnered with multiple stakeholders, such as professional anesthesiology societies, academic research institutions, patient advocacy groups, industry and other government and nonprofit organizations, to launch the SAFEKIDS Initiative.

Additional Information:

FDA. Safety of Key Inhaled and Intravenous Drugs in Pediatrics: (SAFEKIDS) Initiative. December 20, 2010.
http://www.fda.gov/AboutFDA/PartnershipsCollaborations/PublicPrivatePartnershipProgram/ucm231126.htm

FDA Press Release. FDA Launches SAFEKIDS Initiative with Academic and Clinical Partners Public-Private Partnership - Will Assess Safety of Anesthetics and Sedatives in Young Children. March 13, 2009.
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2009/ucm149543.htm


MedSun Newsletters are available at www.fda.gov/cdrh/medsun